G Roupe
Overview
Explore the profile of G Roupe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roupe G
Lakartidningen
. 2001 Apr;
98(10):1091-5.
PMID: 11301975
Cutaneous aging includes true aging and photo-aging due to sun exposure. A decrease in epidermal turnover rate results in epidermal atrophy and delayed wound-healing. A reduction in the number of...
2.
Krogstad A, Roupe G
Exp Dermatol
. 2001 Mar;
10(2):118-23.
PMID: 11260250
Mastocytosis represents a group of disorders characterized by the proliferation and accumulation of mast cells in tissue. The aim of the present study was to examine whether the interstitial histamine...
3.
Swolin B, Rodjer S, Roupe G
Cancer Genet Cytogenet
. 2000 Aug;
120(2):131-5.
PMID: 10942803
Chromosomal aberrations in hematopoietic cells are common in malignant hematological disorders and have also been reported in some patients with mastocytosis. In this study, 34 patients with either urticaria pigmentosa...
4.
Granerus G, Lonnqvist B, Nystrand J, Roupe G
Br J Dermatol
. 1999 Jan;
139(5):858-61.
PMID: 9892955
Serum tryptase was measured with the B12 and G5 antibody-based immunoassays in 25 adult patients with mastocytosis and in 18 controls. Twelve patients had uncomplicated cutaneous mastocytosis (urticaria pigmentosa) and...
5.
Roupe G, Sandstrom M, Kjellstrom C
Acta Derm Venereol
. 1996 Nov;
76(6):475-8.
PMID: 8982416
We report a follow-up for 3-18 years of 24 patients with the non-infiltrated patch and infiltrated plaque stage of mycosis fungoides, treated with psoralen photochemotherapy (PUVA) and on resistant infiltration...
6.
Granerus G, Lonnqvist B, Roupe G
Inflamm Res
. 1996 Mar;
45 Suppl 1:S41-3.
PMID: 8696923
No abstract available.
7.
Johansson C, Roupe G, Lindstedt G, Mellstrom D
Age Ageing
. 1996 Jan;
25(1):1-7.
PMID: 8670521
We examined the association between severity of disease in mastocytosis and skeletal manifestation and bone markers in 16 patients varying in extent of mastocytosis as determined by the urine excretion...
8.
SWANBECK G, Roupe G, Sandstrom M
Acta Derm Venereol
. 1994 Nov;
74(6):465-6.
PMID: 7701883
PUVA therapy has its roots in ancient India and Egypt and began to come into general use in the highly developed countries in the middle of the 1970's (1). The...
9.
Granerus G, Lonnqvist B, Roupe G
Agents Actions
. 1994 Jun;
41 Spec No:C127-8.
PMID: 7526641
To test the hypothesis that histamine release in mastocytosis patients generally occurs without activation of the mast cells, histamine turnover, measured as histamine metabolite excretion in the urine, was compared...
10.
Swolin B, Rodjer S, Jonell R, Roupe G
Acta Derm Venereol
. 1994 May;
74(3):163-7.
PMID: 7915453
Proliferation of mast cells can give rise to many clinical manifestations in patients, and an association with hematological disorders has been pointed out. The study was initiated to determine whether...